Eravacycline Dihydrochloride and Ruxolitinib Phosphate

• Generic Name: eravacycline
• Dosage Forms: n.a.
• Other Brand Names: Xerava

Eravacycline dihydrochloride is a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections (cIAI) in patients 18 years of age and older.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of eravacycline dihydrochloride and other antibacterial drugs, eravacycline dihydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.

Eravacycline dihydrochloride is not indicated for the treatment of complicated urinary tract infections (cUTI).

• Generic Name: ruxolitinib
• Dosage Forms: n.a.
• Other Brand Names: Jakafi

Treatment of intermediate- or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis, and post-essential thrombocythemia myelofibrosis (designated an orphan drug by FDA for this use).